A citation-based method for searching scientific literature

A K Vaishnaw, J R Orlinick, J L Chu, P H Krammer, M V Chao, K B Elkon. J Clin Invest 1999
Times Cited: 124







List of co-cited articles
629 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
61

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
F Rieux-Laucat, F Le Deist, C Hivroz, I A Roberts, K M Debatin, A Fischer, J P de Villartay. Science 1995
56

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
C E Jackson, R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller,[...]. Am J Hum Genet 1999
162
40

Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
D A Martin, L Zheng, R M Siegel, B Huang, G H Fisher, J Wang, C E Jackson, J M Puck, J Dale, S E Straus,[...]. Proc Natl Acad Sci U S A 1999
145
38

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
F Rieux-Laucat, S Blachère, S Danielan, J P De Villartay, M Oleastro, E Solary, B Bader-Meunier, P Arkwright, C Pondaré, F Bernaudin,[...]. Blood 1999
117
35


Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
J Wang, L Zheng, A Lobito, F K Chan, J Dale, M Sneller, X Yao, J M Puck, S E Straus, M J Lenardo. Cell 1999
465
32

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
M C Sneller, J Wang, J K Dale, W Strober, L A Middelton, Y Choi, T A Fleisher, M S Lim, E S Jaffe, J M Puck,[...]. Blood 1997
269
32

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
R M Siegel, J K Frederiksen, D A Zacharias, F K Chan, M Johnson, D Lynch, R Y Tsien, M J Lenardo. Science 2000
499
30

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
S E Straus, E S Jaffe, J M Puck, J K Dale, K B Elkon, A Rösen-Wolff, A M Peters, M C Sneller, C W Hallahan, J Wang,[...]. Blood 2001
307
29

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
J Wu, J Wilson, J He, L Xiang, P H Schur, J D Mountz. J Clin Invest 1996
347
27

Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
A Bettinardi, D Brugnoni, E Quiròs-Roldan, A Malagoli, S La Grutta, A Correra, L D Notarangelo. Blood 1997
157
26

Chronic lymphadenopathy simulating malignant lymphoma.
V C Canale, C H Smith. J Pediatr 1967
145
22

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
R Watanabe-Fukunaga, C I Brannan, N G Copeland, N A Jenkins, S Nagata. Nature 1992
21

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
M C Sneller, S E Straus, E S Jaffe, J S Jaffe, T A Fleisher, M Stetler-Stevenson, W Strober. J Clin Invest 1992
232
21

Clinical, immunological, and pathological consequences of Fas-deficient conditions.
F Le Deist, J F Emile, F Rieux-Laucat, M Benkerrou, I Roberts, N Brousse, A Fischer. Lancet 1996
152
21

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
497
21

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
195
20

Pathological findings in human autoimmune lymphoproliferative syndrome.
M S Lim, S E Straus, J K Dale, T A Fleisher, M Stetler-Stevenson, W Strober, M C Sneller, J M Puck, M J Lenardo, K S Elenitoba-Johnson,[...]. Am J Pathol 1998
146
19

The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
A J Infante, H A Britton, T DeNapoli, L A Middelton, M J Lenardo, C E Jackson, J Wang, T Fleisher, S E Straus, J M Puck. J Pediatr 1998
88
20

Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder.
Y Kasahara, T Wada, Y Niida, A Yachie, H Seki, Y Ishida, T Sakai, F Koizumi, S Koizumi, T Miyawaki,[...]. Int Immunol 1998
72
25

The Fas death factor.
S Nagata, P Golstein. Science 1995
16

Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.
K Grønbaek, P T Straten, E Ralfkiaer, V Ahrenkiel, M K Andersen, N E Hansen, J Zeuthen, K Hou-Jensen, P Guldberg. Blood 1998
250
16

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
S E Straus, M Sneller, M J Lenardo, J M Puck, W Strober. Ann Intern Med 1999
230
16

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
T Takahashi, M Tanaka, C I Brannan, N A Jenkins, N G Copeland, T Suda, S Nagata. Cell 1994
16

Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
M van der Burg, R de Groot, W M Comans-Bitter, J C den Hollander, H Hooijkaas, H J Neijens, R M Berger, A P Oranje, A W Langerak, J J van Dongen. Pediatr Res 2000
41
39

Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
U Dianzani, M Bragardo, D DiFranco, C Alliaudi, P Scagni, D Buonfiglio, V Redoglia, S Bonissoni, A Correra, I Dianzani,[...]. Blood 1997
129
15

Apoptosis by death factor.
S Nagata. Cell 1997
15

NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain.
B Huang, M Eberstadt, E T Olejniczak, R P Meadows, S W Fesik. Nature 1996
305
15

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.
N Itoh, S Yonehara, A Ishii, M Yonehara, S Mizushima, M Sameshima, A Hase, Y Seto, S Nagata. Cell 1991
14

Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.
F C Kischkel, S Hellbardt, I Behrmann, M Germer, M Pawlita, P H Krammer, M E Peter. EMBO J 1995
14


Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
J J Bleesing, M R Brown, S E Straus, J K Dale, R M Siegel, M Johnson, M J Lenardo, J M Puck, T A Fleisher. Blood 2001
93
15


Inhibition of death receptor signals by cellular FLIP.
M Irmler, M Thome, M Hahne, P Schneider, K Hofmann, V Steiner, J L Bodmer, M Schröter, K Burns, C Mattmann,[...]. Nature 1997
12

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
F Rieux-Laucat, F Le Deist, A Fischer. Cell Death Differ 2003
149
12


Death receptors: signaling and modulation.
A Ashkenazi, V M Dixit. Science 1998
11

Mutations in the Fas antigen in patients with multiple myeloma.
T H Landowski, N Qu, I Buyuksal, J S Painter, W S Dalton. Blood 1997
191
11

Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.
S Tamiya, K Etoh, H Suzushima, K Takatsuki, M Matsuoka. Blood 1998
118
11

Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis.
L Pensati, A Costanzo, A Ianni, D Accapezzato, R Iorio, G Natoli, R Nisini, C Almerighi, C Balsano, P Vajro,[...]. Gastroenterology 1997
53
20


FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.
M Muzio, A M Chinnaiyan, F C Kischkel, K O'Rourke, A Shevchenko, J Ni, C Scaffidi, J D Bretz, M Zhang, R Gentz,[...]. Cell 1996
11

Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.
U Ramenghi, S Bonissoni, G Migliaretti, S DeFranco, F Bottarel, C Gambaruto, D DiFranco, R Priori, F Conti, I Dianzani,[...]. Blood 2000
81
13

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression.
U Lopatin, X Yao, R K Williams, J J Bleesing, J K Dale, D Wong, J Teruya-Feldstein, S Fritz, M R Morrow, I Fuss,[...]. Blood 2001
74
14

Haploinsufficiency, rather than the effect of an excessive production of soluble CD95 (CD95{Delta}TM), is the basis for ALPS Ia in a family with duplicated 3' splice site AG in CD95 intron 5 on one allele.
Joachim Roesler, Jose-Maria Izquierdo, Martin Ryser, Angela Rösen-Wolff, Manfred Gahr, Juan Valcarcel, Michael J Lenardo, Lixin Zheng. Blood 2005
33
33

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.
J Cheng, T Zhou, C Liu, J P Shapiro, M J Brauer, M C Kiefer, P J Barr, J D Mountz. Science 1994
10

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain.
M P Boldin, E E Varfolomeev, Z Pancer, I L Mett, J H Camonis, D Wallach. J Biol Chem 1995
909
10

Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation.
B J Sleight, V S Prasad, C DeLaat, P Steele, E Ballard, R J Arceci, C L Sidman. Bone Marrow Transplant 1998
38
26

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.
M Lenardo, K M Chan, F Hornung, H McFarland, R Siegel, J Wang, L Zheng. Annu Rev Immunol 1999
783
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.